Stroke is the leading cause of seizures and epilepsy in older adults. Patients who have
larger and more severe strokes involving the cortex, are younger, and have acute …

The numbers of patients with dementia and patients with epilepsy are increasing in the
global population. In fact, these two conditions are related, and it is estimated that at least 5 …

Introduction We report outcomes from an open-label, non-randomized, 24-week study of
eslicarbazepine acetate (ESL) in adults at earlier and later stages of their treatment history …

Background and Objectives: Hyponatremia is one of the most common adverse effects in
patients treated with oxcarbazepine (OXC). Different risk factors for OXC-induced …

Abstract Objective In Europe, eslicarbazepine acetate (ESL) is approved as adjunctive
therapy for the treatment of focal seizures (FS) in children aged> 6 years. In the US, ESL is …

Eslicarbazepine acetate (Zebinix®), a voltage-gated sodium channel blocker, is a once-
daily, orally administered anti-seizure medication available in the EU for use as …

Eslicarbazepine‐induced severe hyponatremia resulted in generalized tonic‐clonic seizure -
Habib - 2021 - Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to Article …

Eslicarbazepine acetate (ESL) is a novel, once-daily antiseizure medication. We evaluated
the efficacy and safety profile of ESL treatment in epilepsy patients at a single tertiary …